These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

98 related items for PubMed ID: 6442331

  • 21. Immunization with rough mutants of Salmonella minnesota: protective activity of IgM and IgG antibody to the R595 (Re chemotype) mutant.
    McCabe WR, DeMaria A, Berberich H, Johns MA.
    J Infect Dis; 1988 Aug; 158(2):291-300. PubMed ID: 3042871
    [Abstract] [Full Text] [Related]

  • 22. Dose-dependent efficacy of vaccination against K. pneumoniae in high and low antibody responder lines of mice.
    Mouton D, Parant M, Mevel JC, Parant F.
    Immunol Lett; 1987 Apr; 14(4):335-9. PubMed ID: 3294582
    [Abstract] [Full Text] [Related]

  • 23. Immunochemical properties of oligosaccharide-protein conjugates with Klebsiella-K2-specificity. II. Protective capacity of the conjugates and anti-conjugate antibodies against infection with Klebsiella pneumoniae 01:K2 in mice.
    Geyer H, Schlecht S, Himmelspach K.
    Med Microbiol Immunol; 1982 Apr; 171(3):135-43. PubMed ID: 6186899
    [Abstract] [Full Text] [Related]

  • 24. Lipopolysaccharide-induced resistance in mice against ascending urinary tract infection with Klebsiella pneumoniae.
    Chathley UC, Sharma S, Chhibber S.
    Folia Microbiol (Praha); 1996 Apr; 41(4):373-6. PubMed ID: 9131794
    [Abstract] [Full Text] [Related]

  • 25. The sera of patients with Klebsiella infections contain a common anti-DNA idiotype (16/6) Id and anti-polynucleotide activity.
    el-Roiey A, Sela O, Isenberg DA, Feldman R, Colaco BC, Kennedy RC, Shoenfeld Y.
    Clin Exp Immunol; 1987 Mar; 67(3):507-15. PubMed ID: 3301096
    [Abstract] [Full Text] [Related]

  • 26. Vaccination with Klebsiella pneumoniae-derived extracellular vesicles protects against bacteria-induced lethality via both humoral and cellular immunity.
    Lee WH, Choi HI, Hong SW, Kim KS, Gho YS, Jeon SG.
    Exp Mol Med; 2015 Sep 11; 47(9):e183. PubMed ID: 26358222
    [Abstract] [Full Text] [Related]

  • 27. Protection against fatal Klebsiella pneumoniae burn wound sepsis by passive transfer of anticapsular polysaccharide.
    Cryz SJ, Fürer E, Germanier R.
    Infect Immun; 1984 Jul 11; 45(1):139-42. PubMed ID: 6376353
    [Abstract] [Full Text] [Related]

  • 28. Symmetrical peripheral gangrene complicating Klebsiella pneumoniae sepsis associated with antiphospholipid antibodies.
    Yoo JH, Min JK, Kwon SS, Jeong CH, Shin WS.
    Ann Rheum Dis; 2004 Apr 11; 63(4):459-60. PubMed ID: 15020345
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. [Protective effect of Lactobacillus acidophilus on development of infection, caused by Klebsiella pneumoniae].
    Kostiuk OP, Chernyshova LI, Slukvin II.
    Fiziol Zh (1978); 1993 Apr 11; 39(4):62-8. PubMed ID: 8243718
    [Abstract] [Full Text] [Related]

  • 31. [Therapeutic and opsonizing effect of specific antibacterial immunoglobulins in experimental Klebsiella septicemia in mice].
    Trautmann M, Fischer GI, Hahn H.
    Immun Infekt; 1984 Feb 11; 12(1):56-60. PubMed ID: 6398272
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Abolition of resistance to Klebsiella pneumoniae by anti-polymorphonuclear leucocyte IgG.
    Bullen JJ, Leach PA, Lange L.
    Immunology; 1980 Jan 11; 39(1):47-52. PubMed ID: 6991395
    [Abstract] [Full Text] [Related]

  • 34. [Characterization of protective activity in human sera against infection with Klebsiella ozaenae].
    Iwami S.
    Nihon Ika Daigaku Zasshi; 1983 Apr 11; 50(2):264-70. PubMed ID: 6863492
    [No Abstract] [Full Text] [Related]

  • 35. Klebsiella pneumoniae peptidoglycan-associated lipoprotein and murein lipoprotein contribute to serum resistance, antiphagocytosis, and proinflammatory cytokine stimulation.
    Hsieh PF, Liu JY, Pan YJ, Wu MC, Lin TL, Huang YT, Wang JT.
    J Infect Dis; 2013 Nov 15; 208(10):1580-9. PubMed ID: 23911714
    [Abstract] [Full Text] [Related]

  • 36. Cross-protective immunity to Gram-negative bacilli: studies with core glycolipid of Salmonella minnesota and antigens of Streptococcus pneumoniae.
    Young LS, Stevens P.
    J Infect Dis; 1977 Aug 15; 136 Suppl():S174-80. PubMed ID: 19538
    [Abstract] [Full Text] [Related]

  • 37. [Protective effect of the aerosol immunization of mice with the polycomponent vaccine Immunovac VP-4 after the challenge of the animals with Klebsiella pneumoniae virulent strain].
    Solov'ev KG, Kurbatova EA, Egorova NB, Uspenskaia SN, Tret'iakova AV, Varfolomeev AN, Gruber IM, Efremova VN, Akhmatova NK, Diadizhshev NR, Akhmatova IB, Diadishchev NR, Semenova IB, Cherkasova LS, Semenov BF, Borovik RV.
    Zh Mikrobiol Epidemiol Immunobiol; 2006 Aug 15; (1):20-5. PubMed ID: 16532635
    [Abstract] [Full Text] [Related]

  • 38. Potential of Klebsiella pneumoniae cytotoxin toxoid as vaccine against klebsiellosis in rabbits and mice.
    Singh BR, Sharma VD.
    Vaccine; 2001 Aug 14; 19(31):4505-10. PubMed ID: 11483277
    [Abstract] [Full Text] [Related]

  • 39. IgA antibody response to klebsiella in ankylosing spondylitis measured by immunoblotting.
    Shodjai-Moradi F, Ebringer A, Abuljadayel I.
    Ann Rheum Dis; 1992 Feb 14; 51(2):233-7. PubMed ID: 1550409
    [Abstract] [Full Text] [Related]

  • 40. The non-conventional MHC class I MR1 molecule controls infection by Klebsiella pneumoniae in mice.
    Georgel P, Radosavljevic M, Macquin C, Bahram S.
    Mol Immunol; 2011 Feb 14; 48(5):769-75. PubMed ID: 21190736
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.